摘要
目的探讨环甲膜穿刺气管内给药在肺结核合并糖尿病治疗中的作用。方法将120例患者随机分为化疗+环甲膜治疗组和单纯化疗对照组,观察临床疗效。结果两组患者痰菌阴转率有显著性差异(P<0.05),胸片或胸部CT提示空洞闭合或缩小,肺部病灶明显吸收有显著性差异(P<0.05)。结论环甲膜穿刺气管内给药能提高肺结核合并糖尿病患者痰菌阴转率,提高疗效,缩短疗程。
Objective To investigate the clinical effect of pulmonary tuberculosis complicated with diabetic disease via cricothyroid membrane puncture. Methods 120 cases were divided into treatment group (chemotherapy combined with cricothyroid membrane puncture) and control group( simply chemotherapy). The clinical therapeutic effects were observed. Results The sputum negative conversion rate and chest focus absorptivity of the treatment group was significantly different from the control group (P 〈 0.05 ). Conclusion Cricothyroid membrane puncture can elevate the sputum negative conversion rate, and shorten the treatment process.
出处
《临床肺科杂志》
2010年第5期691-692,共2页
Journal of Clinical Pulmonary Medicine
关键词
环甲膜穿刺
气管内给药
肺结核合并糖尿病
cricothyroid membrane puncture
intratracheal administration
pulmonary tuberculosis complicated with diabetic disease